Atlas Trials

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Clinical trial NCT01785771 · TERMINATED

Trial details

NCT number
NCT01785771
Sponsor
Intarcia Therapeutics
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2013-05-01
Primary completion
2018-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.